Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-15 Sale | 2025-01-17 4:07 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 2,383 | $23.83 | $56,782 | 359,408 (Direct) | View |
| 2025-01-15 Sale | 2025-01-17 4:05 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 2,298 | $23.83 | $54,757 | 324,766 (Direct) | View |
| 2025-01-15 Sale | 2025-01-17 4:04 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 8,767 | $23.83 | $208,900 | 964,225 (Direct) | View |
| 2025-01-13 Purchase | 2025-01-15 4:36 pm | Immunovant Inc. | IMVT | Roivant Sciences Ltd. Director 10% Owner | 16,845,010 | $20 | $336,900,200 | 96,650,341 (Direct) | View |
| 2025-01-08 Sale | 2025-01-10 4:12 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 4,105 | $24.1 | $98,931 | 327,064 (Direct) | View |
| 2025-01-08 Sale | 2025-01-10 4:11 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 5,105 | $24.1 | $123,031 | 972,992 (Direct) | View |
| 2024-12-02 Sale | 2024-12-04 4:22 pm | Immunovant Inc. | IMVT | Pande Atul Director | 7,750 | $28.54 | $221,185 | 106,663 (Indirect Direct) | View |
| 2024-12-02 Sale | 2024-12-04 4:20 pm | Immunovant Inc. | IMVT | Hughes Douglas J. Director | 5,425 | $28.54 | $154,830 | 119,585 (Direct) | View |
| 2024-11-20 Sale | 2024-11-22 4:12 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 3,650 | $25.45 | $92,893 | 319,228 (Direct) | View |
| 2024-11-20 Sale | 2024-11-22 4:11 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 3,353 | $25.45 | $85,334 | 361,791 (Direct) | View |
| 2024-11-20 Sale | 2024-11-22 4:09 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 4,174 | $25.45 | $106,228 | 331,169 (Direct) | View |
| 2024-11-20 Sale | 2024-11-22 4:08 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 16,692 | $25.45 | $424,811 | 978,097 (Direct) | View |
| 2024-10-23 Sale | 2024-10-25 4:25 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 4,361 | $29.53 | $128,780 | 322,878 (Direct) | View |
| 2024-10-23 Sale | 2024-10-25 4:23 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 3,189 | $29.53 | $94,171 | 134,971 (Direct) | View |
| 2024-10-23 Sale | 2024-10-25 4:21 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 2,740 | $29.53 | $80,912 | 142,186 (Direct) | View |
| 2024-10-16 Sale | 2024-10-18 4:31 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 9,095 | $28.79 | $261,845 | 994,789 (Direct) | View |
| 2024-10-16 Sale | 2024-10-18 4:30 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 3,188 | $28.79 | $91,783 | 365,144 (Direct) | View |
| 2024-10-16 Sale | 2024-10-18 4:28 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 2,860 | $28.79 | $82,339 | 327,239 (Direct) | View |
| 2024-10-16 Sale | 2024-10-18 4:27 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 3,271 | $28.79 | $94,172 | 335,343 (Direct) | View |
| 2024-10-09 Sale | 2024-10-11 4:04 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 5,162 | $29.56 | $152,589 | 338,614 (Direct) | View |
| 2024-10-09 Sale | 2024-10-11 4:02 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 4,460 | $29.56 | $131,838 | 1,003,884 (Direct) | View |
| 2024-08-21 Sale | 2024-08-23 4:15 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 3,295 | $31.86 | $104,976 | 330,099 (Direct) | View |
| 2024-08-21 Sale | 2024-08-23 4:14 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 3,027 | $31.86 | $96,437 | 368,332 (Direct) | View |
| 2024-08-21 Sale | 2024-08-23 4:11 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 3,768 | $31.86 | $120,045 | 343,776 (Direct) | View |
| 2024-08-21 Sale | 2024-08-23 4:10 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 3,027 | $31.86 | $96,437 | 440,959 (Direct) | View |
| 2024-08-21 Sale | 2024-08-23 4:07 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 15,068 | $31.86 | $480,052 | 1,008,344 (Direct) | View |
| 2024-07-24 Sale | 2024-07-26 4:20 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 2,813 | $27.76 | $78,089 | 144,926 (Direct) | View |
| 2024-07-24 Sale | 2024-07-26 4:19 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 3,456 | $27.76 | $95,939 | 138,160 (Direct) | View |
| 2024-07-24 Sale | 2024-07-26 4:17 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 4,015 | $27.76 | $111,456 | 333,394 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 5:42 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 2,505 | $29.69 | $74,382 | 337,409 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 5:41 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 3,044 | $29.69 | $90,386 | 371,359 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 5:39 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 3,123 | $29.69 | $92,733 | 347,544 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 5:38 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 2,867 | $29.69 | $85,132 | 443,986 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 5:36 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 8,685 | $29.69 | $257,888 | 1,023,412 (Direct) | View |
| 2024-07-09 Sale | 2024-07-10 5:07 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 4,747 | $28.06 | $133,201 | 350,667 (Direct) | View |
| 2024-07-09 Sale | 2024-07-10 5:06 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 1,527 | $28.06 | $42,848 | 446,853 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-16 Option Award | 2024-12-18 5:02 pm | N/A 2034-12-16 | Immunovant Inc. | IMVT | Van Tuyl Christopher Chief Legal Officer | 247,402 | $0 | 247,402 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-20 5:15 pm | N/A 2034-11-18 | Immunovant Inc. | IMVT | Gloria Melanie Chief Operating Officer | 247,402 | $0 | 247,402 (Direct) | View |